{"id":1833790,"date":"2024-03-21T21:25:46","date_gmt":"2024-03-21T21:25:46","guid":{"rendered":"https:\/\/www.pressenza.com\/?p=1833790"},"modified":"2024-03-21T21:25:46","modified_gmt":"2024-03-21T21:25:46","slug":"la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea","status":"publish","type":"post","link":"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/","title":{"rendered":"La Salut abans que el  mercat&#8230; canviem Europa! IV: la farm\u00e0cia europea"},"content":{"rendered":"<p><strong><em>Aquest document \u00e9s una s\u00edntesi d&#8217;una de les diverses fitxes de treball elaborades per la xarxa europea <\/em><\/strong><strong><em>People&#8217;s Health Movement<\/em><\/strong><em>, l&#8217;<\/em> <strong><em>European Federation of Public Service Unions<\/em><\/strong><em> ( Federaci\u00f3 europea de sindicats de serveis p\u00fablics \u2013 <strong>EPSU<\/strong>) <\/em><em>i la <strong>Reseau Europeen contre la Privatisation et la Commercialisation de la Sant\u00e9 et de la Protection Sociale<\/strong>, en la que participa la <strong>Marea Blanca de Catalunya<\/strong>, i <\/em><em>que pretenen acabar en propostes emmarcades en la campanya \u201c<\/em><strong><em>La Salut enfront del mercat: canviem Europa<\/em><\/strong><em>\u201d, ara que s&#8217;apropen les eleccions europees.<\/em><\/p>\n<p><strong>Per la nostra salut, volem una Europa que desenvolupi una pol\u00edtica de medicaments al servei de la poblaci\u00f3 d&#8217;Europa i del Sud, i no en favor de les\u00a0 multinacionals farmac\u00e8utiques.<\/strong><\/p>\n<p>Avui dia, els medicaments s\u00f3n desenvolupats, produ\u00efts i comercialitzats per empreses privades. La\u00a0 seva\u00a0 rendibilitat\u00a0\u00a0 t\u00e9 prioritat sobre la salut p\u00fablica. Malauradament, la pand\u00e8mia de la Covid-19 n&#8217;ha estat un exemple dram\u00e0tic en l&#8217;\u00e0mbit europeu. En total opacitat, la Uni\u00f3 Europea ha pagat desenes de milers de milions d&#8217;euros, de diners p\u00fablics, per comprar vacunes anticovid. No obstant aix\u00f2, aquestes vacunes nom\u00e9s van poder veure la llum gr\u00e0cies a una aflu\u00e8ncia massiva de diners p\u00fablics i a aven\u00e7os en la investigaci\u00f3 p\u00fablica (patent de 2005 de la Universitat de Pensilv\u00e0nia, que redueix el car\u00e0cter inflamatori amb les vacunes d&#8217;ARN, i patent 070 del govern nord-americ\u00e0, que permet estabilitzar fragment d&#8217;ARN mitjan\u00e7ant microperles l\u00edpids). D&#8217;una banda, la ind\u00fastria farmac\u00e8utica va vendre els seus vaccins a un preu elevat als pa\u00efsos m\u00e9s rics; de l&#8217;altra, en oposar-se a l&#8217;eliminaci\u00f3 de les patents, van privar de vacunes els pobles dels pa\u00efsos menys rics. L&#8217;associaci\u00f3 Global Justice Now, fent servir dades d&#8217;Our World in Data, va estimar les conseq\u00fc\u00e8ncies en m\u00e9s de 10.000 morts evitables al dia.<\/p>\n<p>La posici\u00f3 de monopoli de les ind\u00fastries farmac\u00e8utiques sobre els medicaments, que els confereixen les patents i els drets de propietat intel\u00b7lectual, aix\u00ed com les expectatives dels pacients d&#8217;accedir a nous medicaments per a patologies poc o mal tractades, empenyen els estats a acceptar condicions financeres injustificables. El cost dels medicaments va augmentar la despesa p\u00fablica dels Estats membres europeus en un 76%, entre 2000 i 2009. Aix\u00f2 ha pressionat els pressupostos dels sistemes socials sanitaris a tots els pa\u00efsos europeus. Al mateix temps, els marges de benefici dels grups farmac\u00e8utics continuen augmentant, i\u00a0 arriben\u00a0 gaireb\u00e9 al 25%.<\/p>\n<p>Vincent Kiezebrink, investigador de Somo, va poder estimar que la taxa de benefici de Moderna amb la seva vacuna anti-Covid rondava el 44%, la de Pfizer al voltant del 50%. Aquests grups farmac\u00e8utics s&#8217;han convertit en unes de les pot\u00e8ncies m\u00e9s importants del sector econ\u00f2mic. Les farmac\u00e8utiques gasten, almenys, 40 milions d&#8217;euros a l&#8217;any fent lobby a Europa. Aix\u00f2 \u00e9s quinze vegades m\u00e9s que la despesa del lobby de la societat civil en salut p\u00fablica. L\u2019experi\u00e8ncia inacceptable del cas de les vacunes Covid i el vergony\u00f3s negoci i impunitat de les grans empreses (Pfizer i Moderna al capdavant) s\u00f3n inacceptables. No es pot tolerar l&#8217;absoluta manca de transpar\u00e8ncia o control des de les autoritats en farm\u00e0cia, comen\u00e7ant per la UE.<\/p>\n<p>Diferents mecanismes en l&#8217;\u00e0mbit europeu condueixen a un augment dels pressupostos p\u00fablics\u00a0 destinats a la despesa en medicaments:<\/p>\n<ul>\n<li><strong> Els Tractats de lliure comer\u00e7 i la lliure inversi\u00f3.<\/strong><\/li>\n<\/ul>\n<p>Aquests tractats protegeixen els interessos econ\u00f2mics de la ind\u00fastria farmac\u00e8utica. Aquests tractats (TTIP, CETA, etc.) preveuen l&#8217;exclusivitat de les dades dels assaigs cl\u00ednics o la confidencialitat de la informaci\u00f3 sobre les empreses, sota amena\u00e7a de sancions severes. Amb el tribunal arbitral el benefici dels interessos econ\u00f2mics de les multinacionals supera l\u2019inter\u00e8s p\u00fablic.<\/p>\n<ul>\n<li><strong> La concessi\u00f3 de subvencions europees a trav\u00e9s d&#8217;associacions publicoprivades.<\/strong><\/li>\n<\/ul>\n<p>Les institucions europees han finan\u00e7at un projecte publicoprivat de 5.300 milions d&#8217;euros adaptat a les demandes de la ind\u00fastria farmac\u00e8utica (Iniciativa de Medicaments Innovadors). Per\u00f2 s\u00f3n\u00a0 les empreses comercials\u00a0\u00a0 les que s&#8217;apropien de tots els beneficis.<\/p>\n<ul>\n<li><strong> El sistema de patents i preus.<\/strong><\/li>\n<\/ul>\n<p>\u00c9s l&#8217;Ag\u00e8ncia Europea de Medicaments la que avalua i controla els medicaments a la Uni\u00f3 Europea, en inter\u00e8s de la salut p\u00fablica. En diverses ocasions ha estat acusada d&#8217;estar subordinada als\u00a0 interessos de la ind\u00fastria i de manca de transpar\u00e8ncia en contra de la missi\u00f3 que se li ha confiat.<\/p>\n<p>Tot i aix\u00f2, concedeix autoritzaci\u00f3 al 90% dels nous medicaments que gaireb\u00e9 no aporten cap valor afegit per a la salut, en comparaci\u00f3 amb els medicaments existents. Aix\u00f2 alenteix l&#8217;\u00fas de medicaments gen\u00e8rics. D&#8217;altra banda, el preu i les condicions de reemborsament s\u00f3n fixats per les autoritats nacionals dels estats membres a trav\u00e9s d&#8217;un sistema opac que permet un benefici excessiu, sense regulaci\u00f3 europea.<\/p>\n<p>Les limitacions pressupost\u00e0ries, en mat\u00e8ria de salut, defensades per Europa condueixen a la privatitzaci\u00f3 dels costos dels medicaments, o pagats directament pels pacients o mitjan\u00e7ant assegurances complement\u00e0ries (les primes de les quals augmenten r\u00e0pidament). En els darrers anys, les empreses farmac\u00e8utiques han organitzat una escassetat de determinats medicaments, creant aix\u00ed<\/p>\n<p>una pressi\u00f3 addicional sobre el preu de venda, sense que Europa hagi reaccionat.<\/p>\n<ul>\n<li><strong> Els medicaments innovadors<\/strong><\/li>\n<\/ul>\n<p>Manca col\u00b7laboraci\u00f3 a europea a l&#8217;hora de negociar els preus d&#8217;aquests medicaments. Un exemple: La multinacional Gilead posseeix la patent del Sofosbuvir. El cost de producci\u00f3 d&#8217;un tractament amb Sofosbuvir \u00e9s de 100 \u20ac. El preu de venda va ser de 30.000 lliures esterlines al Regne Unit, 84.000 d\u00f2lars als Estats Units, 40.000 euros a B\u00e8lgica i 41.000 euros a It\u00e0lia i Fran\u00e7a. La investigaci\u00f3 per a aquest tractament va ser realitzada per una universitat p\u00fablica i despr\u00e9s Gilead va comprar els resultats.<\/p>\n<p>Despr\u00e9s de menys d&#8217;un any al mercat, s&#8217;han reemborsat tots els costos d&#8217;inversi\u00f3.<\/p>\n<p><strong>Les nostres prioritats<\/strong><\/p>\n<ul>\n<li>Els medicaments essencials han de ser \u201caccessibles, disponibles, econ\u00f2micament assequibles, de bona qualitat i ben utilitzats\u201d per a satisfer les necessitats de milers de milions d&#8217;\u00e9ssers humans a Europa i altres parts del m\u00f3n.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li>En cas que estigui disponible un recurs gen\u00e8ric, l&#8217;hem de prioritzar a trav\u00e9s de la contractaci\u00f3 p\u00fablica. Quan un medicament es ven a un preu anormalment alt, la producci\u00f3 d&#8217;unitats del medicament, abans que expiri la patent, hauria de ser possible mitjan\u00e7ant la concessi\u00f3 de llic\u00e8ncies obligat\u00f2ries. En conseq\u00fc\u00e8ncia, s&#8217;hauria de facilitar l&#8217;\u00fas de llic\u00e8ncies obligat\u00f2ries. Durant una crisi sanit\u00e0ria com la pand\u00e8mia de la COVID, l\u2019aixecament de les patents de totes les ter\u00e0pies hauria d\u2019haver estat fonamental.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li>Les institucions europees, com l&#8217;EMA i la Comissi\u00f3 Europea, han de donar suport al desenvolupament de nous models de recerca i desenvolupament, producci\u00f3 i distribuci\u00f3 de productes de qualitat, com a principis basats en la \u201cci\u00e8ncia oberta\u201d i llic\u00e8ncies socialment responsables, basades en criteris m\u00e8dics i necessitats socials. \u00c9s necessari fomentar i finan\u00e7ar la cooperaci\u00f3 internacional<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li>\u00c9s necessari establir una millor col\u00b7laboraci\u00f3 entre els estats membres i les institucions europees per avaluar el valor real d&#8217;un nou f\u00e0rmac, el cost del desenvolupament i l&#8217;acc\u00e9s a tota la informaci\u00f3 \u00fatil.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li>Cal determinar millor la naturalesa innovadora i la necessitat social i terap\u00e8utica en relaci\u00f3 amb les alternatives ja disponibles al mercat de medicaments (medicaments gen\u00e8rics i bio similars, per exemple).<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Aquest document \u00e9s una s\u00edntesi d&#8217;una de les diverses fitxes de treball elaborades per la xarxa europea People&#8217;s Health Movement, l&#8217; European Federation of Public Service Unions ( Federaci\u00f3 europea de sindicats de serveis p\u00fablics \u2013 EPSU) i la Reseau&hellip;<\/p>\n","protected":false},"author":1122,"featured_media":1833792,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32516],"tags":[],"class_list":["post-1833790","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-internacional-ca"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La Salut abans que el mercat... canviem Europa! IV: la farm\u00e0cia europea<\/title>\n<meta name=\"description\" content=\"Aquest document \u00e9s una s\u00edntesi d&#039;una de les diverses fitxes de treball elaborades per la xarxa europea People&#039;s Health Movement, l&#039; European Federation of\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La Salut abans que el mercat... canviem Europa! IV: la farm\u00e0cia europea\" \/>\n<meta property=\"og:description\" content=\"Aquest document \u00e9s una s\u00edntesi d&#039;una de les diverses fitxes de treball elaborades per la xarxa europea People&#039;s Health Movement, l&#039; European Federation of\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/\" \/>\n<meta property=\"og:site_name\" content=\"Pressenza\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/PressenzaItalia\" \/>\n<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/Pressenza-Espaa-647854795301395\/timeline\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-21T21:25:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2024\/03\/pexels-photo-8666804.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Redacci\u00f3n Barcelona\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@pressenza\" \/>\n<meta name=\"twitter:site\" content=\"@PressenzaIPA\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Redacci\u00f3n Barcelona\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/\"},\"author\":{\"name\":\"Redacci\u00f3n Barcelona\",\"@id\":\"https:\/\/www.pressenza.com\/ca\/#\/schema\/person\/a9ebd8c3374f0dcd5be95d4461afc4a7\"},\"headline\":\"La Salut abans que el mercat&#8230; canviem Europa! IV: la farm\u00e0cia europea\",\"datePublished\":\"2024-03-21T21:25:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/\"},\"wordCount\":1297,\"publisher\":{\"@id\":\"https:\/\/www.pressenza.com\/ca\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2024\/03\/pexels-photo-8666804.webp\",\"articleSection\":[\"Internacional\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/\",\"url\":\"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/\",\"name\":\"La Salut abans que el mercat... canviem Europa! IV: la farm\u00e0cia europea\",\"isPartOf\":{\"@id\":\"https:\/\/www.pressenza.com\/ca\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2024\/03\/pexels-photo-8666804.webp\",\"datePublished\":\"2024-03-21T21:25:46+00:00\",\"description\":\"Aquest document \u00e9s una s\u00edntesi d'una de les diverses fitxes de treball elaborades per la xarxa europea People's Health Movement, l' European Federation of\",\"breadcrumb\":{\"@id\":\"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/#primaryimage\",\"url\":\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2024\/03\/pexels-photo-8666804.webp\",\"contentUrl\":\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2024\/03\/pexels-photo-8666804.webp\",\"width\":1920,\"height\":1280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.pressenza.com\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La Salut abans que el mercat&#8230; canviem Europa! IV: la farm\u00e0cia europea\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.pressenza.com\/ca\/#website\",\"url\":\"https:\/\/www.pressenza.com\/ca\/\",\"name\":\"Pressenza\",\"description\":\"International Press Agency\",\"publisher\":{\"@id\":\"https:\/\/www.pressenza.com\/ca\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.pressenza.com\/ca\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.pressenza.com\/ca\/#organization\",\"name\":\"Pressenza\",\"url\":\"https:\/\/www.pressenza.com\/ca\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.pressenza.com\/ca\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2022\/10\/pressenza_logo_200x200.jpg\",\"contentUrl\":\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2022\/10\/pressenza_logo_200x200.jpg\",\"width\":200,\"height\":200,\"caption\":\"Pressenza\"},\"image\":{\"@id\":\"https:\/\/www.pressenza.com\/ca\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/PressenzaItalia\",\"https:\/\/x.com\/PressenzaIPA\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.pressenza.com\/ca\/#\/schema\/person\/a9ebd8c3374f0dcd5be95d4461afc4a7\",\"name\":\"Redacci\u00f3n Barcelona\",\"description\":\"News published by the Pressenza bureau in Barcelona, Spain\",\"sameAs\":[\"https:\/\/www.facebook.com\/Pressenza-Espaa-647854795301395\/timeline\/\",\"https:\/\/x.com\/pressenza\"],\"url\":\"https:\/\/www.pressenza.com\/ca\/author\/redaccion-barcelona\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La Salut abans que el mercat... canviem Europa! IV: la farm\u00e0cia europea","description":"Aquest document \u00e9s una s\u00edntesi d'una de les diverses fitxes de treball elaborades per la xarxa europea People's Health Movement, l' European Federation of","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/","og_locale":"ca_ES","og_type":"article","og_title":"La Salut abans que el mercat... canviem Europa! IV: la farm\u00e0cia europea","og_description":"Aquest document \u00e9s una s\u00edntesi d'una de les diverses fitxes de treball elaborades per la xarxa europea People's Health Movement, l' European Federation of","og_url":"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/","og_site_name":"Pressenza","article_publisher":"https:\/\/www.facebook.com\/PressenzaItalia","article_author":"https:\/\/www.facebook.com\/Pressenza-Espaa-647854795301395\/timeline\/","article_published_time":"2024-03-21T21:25:46+00:00","og_image":[{"width":1920,"height":1280,"url":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2024\/03\/pexels-photo-8666804.webp","type":"image\/webp"}],"author":"Redacci\u00f3n Barcelona","twitter_card":"summary_large_image","twitter_creator":"@pressenza","twitter_site":"@PressenzaIPA","twitter_misc":{"Escrit per":"Redacci\u00f3n Barcelona","Temps estimat de lectura":"6 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/#article","isPartOf":{"@id":"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/"},"author":{"name":"Redacci\u00f3n Barcelona","@id":"https:\/\/www.pressenza.com\/ca\/#\/schema\/person\/a9ebd8c3374f0dcd5be95d4461afc4a7"},"headline":"La Salut abans que el mercat&#8230; canviem Europa! IV: la farm\u00e0cia europea","datePublished":"2024-03-21T21:25:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/"},"wordCount":1297,"publisher":{"@id":"https:\/\/www.pressenza.com\/ca\/#organization"},"image":{"@id":"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2024\/03\/pexels-photo-8666804.webp","articleSection":["Internacional"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/","url":"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/","name":"La Salut abans que el mercat... canviem Europa! IV: la farm\u00e0cia europea","isPartOf":{"@id":"https:\/\/www.pressenza.com\/ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/#primaryimage"},"image":{"@id":"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2024\/03\/pexels-photo-8666804.webp","datePublished":"2024-03-21T21:25:46+00:00","description":"Aquest document \u00e9s una s\u00edntesi d'una de les diverses fitxes de treball elaborades per la xarxa europea People's Health Movement, l' European Federation of","breadcrumb":{"@id":"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/#primaryimage","url":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2024\/03\/pexels-photo-8666804.webp","contentUrl":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2024\/03\/pexels-photo-8666804.webp","width":1920,"height":1280},{"@type":"BreadcrumbList","@id":"https:\/\/www.pressenza.com\/ca\/2024\/03\/la-salut-abans-que-el-mercat-canviem-europa-iv-la-farmacia-europea\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.pressenza.com\/ca\/"},{"@type":"ListItem","position":2,"name":"La Salut abans que el mercat&#8230; canviem Europa! IV: la farm\u00e0cia europea"}]},{"@type":"WebSite","@id":"https:\/\/www.pressenza.com\/ca\/#website","url":"https:\/\/www.pressenza.com\/ca\/","name":"Pressenza","description":"International Press Agency","publisher":{"@id":"https:\/\/www.pressenza.com\/ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pressenza.com\/ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.pressenza.com\/ca\/#organization","name":"Pressenza","url":"https:\/\/www.pressenza.com\/ca\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.pressenza.com\/ca\/#\/schema\/logo\/image\/","url":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2022\/10\/pressenza_logo_200x200.jpg","contentUrl":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2022\/10\/pressenza_logo_200x200.jpg","width":200,"height":200,"caption":"Pressenza"},"image":{"@id":"https:\/\/www.pressenza.com\/ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/PressenzaItalia","https:\/\/x.com\/PressenzaIPA"]},{"@type":"Person","@id":"https:\/\/www.pressenza.com\/ca\/#\/schema\/person\/a9ebd8c3374f0dcd5be95d4461afc4a7","name":"Redacci\u00f3n Barcelona","description":"News published by the Pressenza bureau in Barcelona, Spain","sameAs":["https:\/\/www.facebook.com\/Pressenza-Espaa-647854795301395\/timeline\/","https:\/\/x.com\/pressenza"],"url":"https:\/\/www.pressenza.com\/ca\/author\/redaccion-barcelona\/"}]}},"place":"Catalunya - Enric Feliu","original_article_url":"","_links":{"self":[{"href":"https:\/\/www.pressenza.com\/ca\/wp-json\/wp\/v2\/posts\/1833790","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pressenza.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pressenza.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pressenza.com\/ca\/wp-json\/wp\/v2\/users\/1122"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pressenza.com\/ca\/wp-json\/wp\/v2\/comments?post=1833790"}],"version-history":[{"count":0,"href":"https:\/\/www.pressenza.com\/ca\/wp-json\/wp\/v2\/posts\/1833790\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pressenza.com\/ca\/wp-json\/wp\/v2\/media\/1833792"}],"wp:attachment":[{"href":"https:\/\/www.pressenza.com\/ca\/wp-json\/wp\/v2\/media?parent=1833790"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pressenza.com\/ca\/wp-json\/wp\/v2\/categories?post=1833790"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pressenza.com\/ca\/wp-json\/wp\/v2\/tags?post=1833790"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}